CEOs see ChatGPT, generative AI as 'Ozempic' style cure-all

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 34 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 51%

Business Business Headlines News

CEOs see ChatGPT as an 'Ozempic' miracle drug that can cut costs and boost efficiency. Right now, they're wrong.

"Fundamentally, these new systems are going to be destabilizing," Sam Altman, CEO of ChatGPT-maker OpenAI and AI-proponent-in-chief told lawmakers during a recent Congress appearance.

If even the man who stands to profit hugely from the widespread adoption of tools like ChatGPT thinks it'll be"destabilizing", the average CEO should take pause.Employees feeding sensitive or proprietary information into a black-box AI tool owned by a third party Copyright or other issues stemming from companies not vetting the AI tools they use, and the data they're trained onThese problems are already here. Samsung banned its employees from using generative AI tools after finding some of its engineersCitigroup, Goldman Sachs and JPMorgan heavily restricted employee use of ChatGPT, with reports suggesting JPMorgan's decision came about from

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 729. in BUSÄ°NESS

Business Business Latest News, Business Business Headlines